Taken together, these results, for the first time, suggest that TGFβ-induced EMT is accompanied by metabolic changes and small molecule effectors that impact the tumor microenvironment in a manner that is conducive to tumor growth and invasiveness in pancreatic cancer. The gene discussed is TGFB1; the disease is neoplasm.